Pathos
Qi Pan currently serves as the Senior Vice President of Cancer Biology at Pathos, a position held since June 2023. Prior to this role, Qi Pan was the Senior Vice President of R&D at Sema4 from April 2018 to June 2023 and held the title of Vice President of Research and Development at Legend Biotech Co. from August 2017 to January 2018. Previous experience includes serving as Senior Associate Director at Boehringer Ingelheim from March 2012 to July 2017, Group Leader at the Belfer Institute of Applied Cancer Science, Dana-Farber Cancer Institute from 2010 to 2012, Scientist at ZymoGenetics from 2007 to 2009, and Senior Research Associate at Genentech from 2005 to 2007. Educational qualifications include a PhD in Cell/Cellular and Molecular Biology from Harvard University, a Postdoctoral Fellowship in Molecular Biology at Harvard Medical School - Massachusetts General Hospital, and a Bachelor of Science in Biotechnology from Tsinghua University.
This person is not in any teams
This person is not in any offices
Pathos
1 followers
Pathos develops an AI-enabled drug discovery platform to reduce the medication development process. Its self-learning platform utilizes big data, technology, and artificial intelligence to identify targets, validate them, and establish their clinical efficacy. It also helps drug developers to explore novel concepts, and advance breakthroughtherapies. The company's OS platform is capable of managing the entire end-to-end process of designing and developing novel therapeutics.